On the other hand, prediction studies suggest that the lncRNA CARM-mirR-192-LOXL2 axis is associated with poor overall survival, immune infiltration, and immune checkpoint expression in hepatocellular carcinoma [89]. This evidence concerns the gene LOXL2 and hepatocellular carcinoma.